These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins). Hiraiwa M; O'Brien JS; Kishimoto Y; Galdzicka M; Fluharty AL; Ginns EI; Martin BM Arch Biochem Biophys; 1993 Jul; 304(1):110-6. PubMed ID: 8323276 [TBL] [Abstract][Full Text] [Related]
3. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside. Hiraiwa M; Martin BM; Kishimoto Y; Conner GE; Tsuji S; O'Brien JS Arch Biochem Biophys; 1997 May; 341(1):17-24. PubMed ID: 9143348 [TBL] [Abstract][Full Text] [Related]
4. Sphingolipid hydrolase activator proteins and their precursors. Sano A; Hineno T; Mizuno T; Kondoh K; Ueno S; Kakimoto Y; Inui K Biochem Biophys Res Commun; 1989 Dec; 165(3):1191-7. PubMed ID: 2610686 [TBL] [Abstract][Full Text] [Related]
5. Saposin proteins: structure, function, and role in human lysosomal storage disorders. O'Brien JS; Kishimoto Y FASEB J; 1991 Mar; 5(3):301-8. PubMed ID: 2001789 [TBL] [Abstract][Full Text] [Related]
6. Identification of a novel sequence involved in lysosomal sorting of the sphingolipid activator protein prosaposin. Zhao Q; Morales CR J Biol Chem; 2000 Aug; 275(32):24829-39. PubMed ID: 10818106 [TBL] [Abstract][Full Text] [Related]
7. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect. Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574 [TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of prosaposin from human milk. Kondoh K; Hineno T; Sano A; Kakimoto Y Biochem Biophys Res Commun; 1991 Nov; 181(1):286-92. PubMed ID: 1958198 [TBL] [Abstract][Full Text] [Related]
9. Secretion of sphingolipid hydrolase activator precursor, prosaposin. Hineno T; Sano A; Kondoh K; Ueno S; Kakimoto Y; Yoshida K Biochem Biophys Res Commun; 1991 Apr; 176(2):668-74. PubMed ID: 2025281 [TBL] [Abstract][Full Text] [Related]
10. An Asn > Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activity. Regis S; Filocamo M; Corsolini F; Caroli F; Keulemans JL; van Diggelen OP; Gatti R Eur J Hum Genet; 1999; 7(2):125-30. PubMed ID: 10196694 [TBL] [Abstract][Full Text] [Related]
11. Biochemistry and neurobiology of prosaposin: a potential therapeutic neuro-effector. Misasi R; Hozumi I; Inuzuka T; Capozzi A; Mattei V; Kuramoto Y; Shimeno H; Soeda S; Azuma N; Yamauchi T; Hiraiwa M Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):119-31. PubMed ID: 20021345 [TBL] [Abstract][Full Text] [Related]
12. Modulation of human saposin B sphingolipid-binding specificity by alternative splicing. A study with saposin B-derived synthetic peptides. Lamontagne S; Potier M J Biol Chem; 1994 Aug; 269(32):20528-32. PubMed ID: 8051151 [TBL] [Abstract][Full Text] [Related]
13. A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse. Matsuda J; Vanier MT; Saito Y; Tohyama J; Suzuki K; Suzuki K Hum Mol Genet; 2001 May; 10(11):1191-9. PubMed ID: 11371512 [TBL] [Abstract][Full Text] [Related]
14. Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse. Matsuda J; Kido M; Tadano-Aritomi K; Ishizuka I; Tominaga K; Toida K; Takeda E; Suzuki K; Kuroda Y Hum Mol Genet; 2004 Nov; 13(21):2709-23. PubMed ID: 15345707 [TBL] [Abstract][Full Text] [Related]
15. Mouse testicular sulfated glycoprotein-1: sequence analysis of the common backbone structure of prosaposins. Zhao Q; Bell AW; El-Alfy M; Morales CR J Androl; 1998; 19(2):165-74. PubMed ID: 9570739 [TBL] [Abstract][Full Text] [Related]
16. Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases. Morimoto S; Yamamoto Y; O'Brien JS; Kishimoto Y Proc Natl Acad Sci U S A; 1990 May; 87(9):3493-7. PubMed ID: 2110365 [TBL] [Abstract][Full Text] [Related]
17. Importance of splicing for prosaposin sorting. Madar-Shapiro L; Pasmanik-Chor M; Vaccaro AM; Dinur T; Dagan A; Gatt S; Horowitz M Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):433-43. PubMed ID: 9895286 [TBL] [Abstract][Full Text] [Related]
18. [Disorders of sphingolipid activator proteins]. Suzuki Y Nihon Rinsho; 1995 Dec; 53(12):3025-7. PubMed ID: 8577053 [TBL] [Abstract][Full Text] [Related]
19. Distribution of saposins (sphingolipid activator proteins) in tissues of lysosomal storage disease patients. Tayama M; O'Brien JS; Kishimoto Y J Mol Neurosci; 1992; 3(4):171-5. PubMed ID: 1389998 [TBL] [Abstract][Full Text] [Related]
20. Structural study of the oligosaccharide moieties of sphingolipid activator proteins, saposins A, C and D obtained from the spleen of a Gaucher patient. Ito K; Takahashi N; Takahashi A; Shimada I; Arata Y; O'Brien JS; Kishimoto Y Eur J Biochem; 1993 Jul; 215(1):171-9. PubMed ID: 8344278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]